healio.com
HUNTINGTON BEACH, Calif. — GLP-1 receptor agonists lead a new wave of therapeutic options that may benefit patients with osteoarthritis, according to data presented at the 2025 Congress of Clinical Rheumatology West.“This field is so barren and the harvest is so small,” Anne Marie Malfait, MD, the George W. Stuppy, MD, chair of arthritis at Rush Medical College in Chicago, said
3 months ago